I for one would like to see Japans Sumitomo renew its interest in BioProspect, or maybe even Chinas Sinochem Even let them do a Nufarm on BPO a lowball TO bid is still a market stimulus. Ensystex could be good in the long run, but I'm not sure they have been proactive as they could have been, I'd be happy if future anns. prove my wrong.